Scholar Rock Holding Corporation (SRRK) — Market Cap, Revenue, Net Income, P/E

Scholar Rock Holding Corporation SRRK

$44.98

▼ -1.14% 24H

About

Scholar Rock Holding Corporation is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for serious diseases where protein growth factor signaling plays a central role. It employs a proprietary platform targeting the transforming growth factor beta (TGFβ) super…

SectorHealthcare

ExchangeNASDAQ

IndustryBiotechnology

CountryUnited States

Employees128

TickerSRRK

Statistics

Market Cap$5.36B

Revenue (TTM)$0

Net Income-$377.9M

Net Margin—

EPS$-3.29

P/E-13.42

P/S—

P/B19.29

EV/EBITDA-12.28

ROE-138.9%

Dividend Yield—

Price$44.98

Data: Twelve Data · Revenue = mcap / P/S